close

August 2017 VOL 8, NO 8

← Back to Issue


Letters from Lillie

Be “In the Know”—JONS Provides the Information Essential to Your Success as a Navigator

Lillie D. Shockney, RN, BS, MAS, ONN-CG 

Dear Navigators,

Not only do navigators have an obligation to their patients, institutions, and themselves to understand and master core competencies of navigation, but they also need to remain up-to-date on the clinical information that impacts their patients. In addition to our presentations of original, peer-reviewed, navigation research articles, it is also our goal to present you with important information from leading oncology meetings in an effort to keep you apprised of the most relevant clinical advances in our field.

In this issue, we present original research as well as coverage from recent oncology meetings. On the navigation front, we feature articles from our own Academy of Oncology Nurse & Patient Navigators (AONN+) West Coast Regional Meeting. To expand our clinical knowledge, we cover topics from the American Society of Clinical Oncology, the American Association for Cancer Research, and the Association of Community Cancer Centers. It is our sincere hope this information is stimulating and helpful to you in your practice.

On behalf of all of us at the Journal of Oncology Navigation & Survivorship (JONS) and AONN+, we applaud your efforts in navigation—both as a pioneer in this relatively new field within oncology nursing and as a dedicated member of the oncology multidisciplinary team. We are here to support you, encourage you, and empower you because your efforts impact patients’ lives for the better every day.

As always, thank you for your loyal readership and for being a part of our navigation community.

Sincerely,

Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+
University Distinguished Service Professor of Breast Cancer; Administrative Director, the Johns Hopkins Breast Center; Director, Cancer Survivorship Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; Professor, JHU School of Medicine, Depts of Surgery and Oncology; Cofounder, Johns Hopkins Medicine Managing Cancer at Work
E-mail: shockli@jhmi.edu

Related Articles
AONN+ Standardized Metrics, AONN+ West Coast Regional Meeting - August 3, 2017

Delving Deeper into the AONN+ Standardized Navigation Metrics

At the Academy of Oncology Nurse & Patient Navigators (AONN+) Annual Meeting in November 2016, the AONN+ Standardized Navigation Metrics Task Force unveiled the first standardized navigation metrics for measuring [ Read More ]

2017 American Society of Clinical Oncology Annual Meeting, Breast Cancer - August 3, 2017

Olaparib Is First PARP Inhibitor to Show Advantage in BRCA-Mutated Breast Cancer

The PARP inhibitor olaparib significantly improved progression-free survival (PFS) compared with standard chemotherapy in women with HER2-negative metastatic breast cancer with a germline BRCA mutation. Disease progression was delayed by [ Read More ]